MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2017 International Congress

    Evaluating Non-Motor Fluctuations in Parkinson’s Disease Using a Visual Analogue Scale

    E. Brown, K. Dodenhoff, J. Ostrem, C. Racine (San Francisco, CA, USA)

    Objective: To further understand non-motor fluctuations (NMF) and their relationship to other symptoms of Parkinson’s disease (PD) in a deep brain stimulation (DBS) population. Background:…
  • 2017 International Congress

    Physical Activity and Quality of Life in People with Parkinson’s Disease – A Long-term Follow-up Study

    I-F. Shih, K. Paul, J. Bronstein, B. Ritz (Los Angeles, CA, USA)

    Objective: This study aims to examine associations between changes in physical activity (PA) and health-related quality of life (HRQOL) among Parkinson disease (PD) patients. Background:…
  • 2017 International Congress

    Does gender influence the expression of non-motor symptoms in Parkinson’s disease?: An observational study

    J. Herreros Rodríguez, A. Esquivel López, R. Gordo Mañas, Á. Sánchez Ferro (Madrid, Spain)

    Objective: Our goal was to evaluate how gender influenced the expression of non-motor symptoms in a sample of PD patients. Background: Parkinson’s Disease (PD) is defined…
  • 2017 International Congress

    Health related QoL as measured by the EQ-5D-5L in PD patients after DBS therapy: Preliminary results from the Product Surveillance Registry

    M. Schiess, J. Krauss, J.-P. Azulay, E. Cuny, A. Lopez Rios, F. Farrokhi, S. Blond, T. Witt, C. Raftopoulos, J. Vesper, B. Van Dorn, T. Weaver, P. Konrad, S. Falowski, S. Palfi (Houston, TX, USA)

    Objective: Summarize change in QoL and health status by comparing scores from the EuroQuol-five domain questionnaire, five level response version (EQ-5D-5L) summary index and Visual Analog Scale (EQ-VAS) obtained at…
  • 2017 International Congress

    Non-motor symptoms in patients with Parkinson’s disease, essential tremor and both diseases – a group comparison

    I. Wurster, A. Abaza, K. Brockmann, M. Rüdiger-Albers, S. Lerche, D. Berg (Tübingen, Germany)

    Objective: To evaluate non-motor symptoms in patients with essential tremor (ET), tremordominant Parkinson’s disease (PD) and those suffering from both diseases (ET-PD). Background: ET is…
  • 2017 International Congress

    The non-motor symptoms in Parkinsons’s disease patients treated with STN DBS: the follow up study

    M. Mencinger, M. Červek, T. Rus, G. Jakob, D. Georgiev, D. Flisar, R. Rajnar, M. Benedičič, K. Boetzel, J. Mehrkens, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

    Objective: The aim of the study was to follow-up the effect of STN DBS on motor and non-motor symptoms in aPD.  Background: A comprehensive assessment…
  • 2017 International Congress

    Validation of the performance based Erlangen Test of Activities of Daily Living in PD

    I. Liepelt-Scarfone, L. Liebig, P. Sulzer, D. Berg (Tübingen, Germany)

    Objective: The Erlangen Test of Activities of Daily Living (E-ADL) is a performance-based test to assess the activity of daily living (ADL) dysfunction associated with…
  • 2017 International Congress

    Axial signs in early-stage Parkinson’s disease :  an influence of the genotype ?

    G. BAILLE, D. DEVOS, V. HUIN, T. PEREZ, B. SABLONNIERE, L. DEFEBVRE, C. MOREAU (CHRU Lille, France)

    Objective: To assess the association between the genotype and the axial signs. Background: Regarding the onset of axial signs in Parkinson’s Disease (PD), heterogeneity has…
  • 2017 International Congress

    Parkinson’s disease patients with cognitive impairment more sensitive to pain?

    K. Abe, K. Fukushima, K. Ando, Y. Maeda, R. Ishikura, H. Yoshikawa (Nishinomiya, Japan)

    Objective: To determine whether parkinson's disease (PD) patients with cognitive impairment is more sensitive for pain than PD patients without cognitive impairment. Background: PD patients…
  • 2017 International Congress

    Parkinson’s disease phenotype across different ethnic groups: Comparison of non-motor symptoms in patients living in the United Kingdom and Mexico

    A. Sauerbier, M. Rodriguez Violante, A. Cervantes Arriaga, A. Rizos, D. Trivedi, P. Martinez-Martin, M. Parry, M. Rosa-Grilo, R. Brown, K. Ray Chaudhuri (London, United Kingdom)

    Objective: The aim is to compare and contrast clinical profiles between UK-White Caucasian (UK-WC), UK-Asian, UK-Black African Caribbean (UK-BAC) and Mexican people with Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 55
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley